论文部分内容阅读
目的:探讨小儿消积止咳口服液联合金叶败毒颗粒治疗急性支气管炎的临床疗效和安全性。方法:收集我院100例急性支气管炎患儿,将其随机分为实验组50例和对照组50例,两组均给予抗感染对症支持治疗。观察组在上述治疗的基础上加小儿消积止咳口服液联合金叶败毒颗粒,观察临床疗效及副反应情况。结果:经过1个疗程的治疗,两组患者症状均有不同程度减轻,两组患者均无明显并发症状。对照组总体有效率为82%,而实验组总体有效率为96%,明显高于对照组,两组间统计分析有统计学差异,P<0.05。结论:小儿消积止咳口服液联合金叶败毒颗粒治疗急性支气管炎临床疗效确切,安全性高,值得临床上推广应用。
Objective: To investigate the clinical efficacy and safety of Xiaoya Xiaoji Zhike oral liquid and Jinye Baidu Granule in the treatment of acute bronchitis. Methods: A total of 100 children with acute bronchitis were collected and randomly divided into experimental group (50 cases) and control group (50 cases). Both groups were given anti-infective symptomatic supportive therapy. Observation group on the basis of the above treatment plus pediatric Xiaoshi Zhike oral Jinyuebaidu drug particles to observe the clinical efficacy and side effects. Results: After one course of treatment, the symptoms of both groups were relieved to varying degrees. There was no obvious complication in both groups. The overall effective rate of the control group was 82%, while the overall effective rate of the experimental group was 96%, which was significantly higher than that of the control group. There was a significant difference between the two groups (P <0.05). Conclusion: Xiaoer Xiaoji Zhike Oral Liquid and Jinye Baidu Decoction are effective and safe in the treatment of acute bronchitis, which is worth popularizing and applying clinically.